DANIEL G. WELCH - 07 Feb 2023 Form 4 Insider Report for Structure Therapeutics Inc. (GPCR)

Role
Director
Signature
/s/ Jun Yoon, Attorney-in-Fact
Issuer symbol
GPCR
Transactions as of
07 Feb 2023
Transactions value $
$0
Form type
4
Filing time
09 Feb 2023, 18:12:00 UTC
Previous filing
02 Feb 2023
Next filing
16 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GPCR Ordinary Shares Conversion of derivative security +124K 124K 07 Feb 2023 By spouse F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GPCR Series B Preferred Shares Conversion of derivative security -124K -100% 0 07 Feb 2023 Ordinary Shares 124K By spouse F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All outstanding Preferred Shares automatically converted into Ordinary Shares immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one Ordinary Share for each one Preferred Share, based on the conversion price currently in effect. The Preferred Shares have no expiration date.